Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	283-284
Journal	The New England journal of medicine
Volume	388
Issue number	3
DOIs	https://doi.org/10.1056/NEJMc2215181
Publication status	Published - 19 Jan 2023

Access to Document

@article{6eac4f85a8cc449f98456a1f7269ade2,

title = "Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo",

author = "Janssen, {Jos{\'e}phine C} and Mulder, {Evalyn E A P} and {van der Veldt}, {Astrid A M}",

year = "2023",

month = jan,

day = "19",

doi = "10.1056/NEJMc2215181",

language = "English",

volume = "388",

pages = "283--284",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "3",

}

TY - JOUR

T1 - Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

AU - Janssen, Joséphine C

AU - Mulder, Evalyn E A P

AU - van der Veldt, Astrid A M

PY - 2023/1/19

Y1 - 2023/1/19

U2 - 10.1056/NEJMc2215181

DO - 10.1056/NEJMc2215181

M3 - Comment/Letter to the editor

C2 - 36652364

SN - 0028-4793

VL - 388

SP - 283

EP - 284

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 3

ER -